Join Our Webinars and Advance Your MedTech Market Access
At athagoras Medtech, our webinars deliver actionable insights on market access, reimbursement, and health economics in Europe. Join our experts live to gain strategic guidance, ask your questions, and discover how to fast-track your medical device, diagnostic, or digital health solution to success.
Tuesday, 21 October 2025
Online
Mattias Kyhlstedt, John West
Webinar
Rethinking UK Market Access for Medtech and Diagnostics
The UK healthcare has evolved substantially in the last decade and it is time to rethink our perspective about market access for Medtech and Diagnostics.
What impact does a NICE recommendation have today, when the ICB’s and Hospitals are in deficit?
Statistics show that there are more than 7 million patients waiting for a hospital visit.
We would suggest that many companies should rethink their market access strategies completely.
- For many companies with new innovative (more expensive) products, UK is not a good market.
- With products that can reduce the cost and improve efficiency UK can be an excellent market.
- The current reality
- Honest perspective of the financial reality within NHS
- What impact will the current policy initiatives have when there is no money attached?
- NHS-10 plan
- ICB restructuring
- Abolition of NHS England
- The role of different programs
- What impact does NICE programs have on market uptake?
- When and how should I engage with the programs:
- Early Value assessment
- Interventional Procedure Guidance
- Health Tech Program (incorporating former Medtech Evaluation Program and Diagnostic Assessment Program)
- Late Stage Assessment (LSA)
- Medtech funding mandate
- Getting it right First Time (GIRFT)
- Cancer Networks
- What is required to be successful in market adoption, considering that the final decisions are taken at a hospital level.